Drug Shortage Report for INHIBACE
Report ID | 114894 |
Drug Identification Number | 01911481 |
Brand name | INHIBACE |
Common or Proper name | INHIBACE 5 MG 100 |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | CILAZAPRIL |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-05-08 |
Estimated end date | 2021-09-30 |
Actual end date | 2021-09-24 |
Shortage status | Resolved |
Updated date | 2021-10-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-10-19 | French | Compare |
v13 | 2021-10-19 | English | Compare |
v12 | 2021-09-02 | French | Compare |
v11 | 2021-09-02 | English | Compare |
v10 | 2021-08-10 | French | Compare |
v9 | 2021-08-10 | English | Compare |
v8 | 2020-10-23 | French | Compare |
v7 | 2020-10-23 | English | Compare |
v6 | 2020-08-31 | French | Compare |
v5 | 2020-08-31 | English | Compare |
v4 | 2020-05-13 | French | Compare |
v3 | 2020-05-13 | English | Compare |
v2 | 2020-05-13 | French | Compare |
v1 | 2020-05-13 | English | Compare |
Showing 1 to 14 of 14